Skip to main content
Top
Published in: Supportive Care in Cancer 4/2020

01-04-2020 | Radiotherapy | Original Article

Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer

Authors: Laura Izabel Lampert Bonzanini, Eloisa Barbieri Soldera, Gabriela Barbieri Ortigara, Riéli Elis Schulz, Raquel Pippi Antoniazzi, Thiago Machado Ardenghi, Kívia Linhares Ferrazzo

Published in: Supportive Care in Cancer | Issue 4/2020

Login to get access

Abstract

Objective

The present cross-sectional study evaluated the quality of life of patients treated with 3-D conformal radiotherapy for cancer of the mouth, oropharynx, hypopharynx, or larynx and investigated possible associations with clinical and sociodemographic variables using multivariate analysis.

Methods

The sample was composed of 90 patients who had completed treatment at least 3 months earlier. Data were collected from April 2016 to May 2017. The patients were clinically evaluated with regard to stimulated salivary flow, trismus, and radiation caries. Sociodemographic data and data related to the disease (stage, location of primary tumor, and radiation dose) were collected from the patient charts. Quality of life was assessed using the Brazilian version of the University of Washington Quality of Life (UW-QOL) questionnaire. Poisson logistic regression was performed to determine the mean ratio and test associations with the clinical and sociodemographic variables.

Results

The mean total of the UW-QOL was 814.88 (± 224.58). Patient age, staging of cancer, hyposalivation, and trismus were associated with quality of life. Patients with tumors in the advanced stage, those with hyposalivation and those with trismus respectively had 11% (CI 0.80–0.98), 12% (CI 0.79–0.99), and 15% (CI 0.77–0.94) lower UW-QOL scores, indicating poorer quality of life.

Conclusion

Survivors of head and neck cancer experience a negative impact on quality of life associated with trismus, hyposalivation, advanced stage tumors, and a younger patient age. The present findings underscore the importance of a specific approach focused on these aspects to ensure better quality of life in the long term.
Literature
5.
go back to reference Andrade FP, Biazevic MG, Toporcov TN, Togni J, de Carvalho MB (2012) Discriminant validity of the University of Washington quality of life questionnaire in the Brazilian context. Rev Bras Epidemiol 15(4):781–789CrossRef Andrade FP, Biazevic MG, Toporcov TN, Togni J, de Carvalho MB (2012) Discriminant validity of the University of Washington quality of life questionnaire in the Brazilian context. Rev Bras Epidemiol 15(4):781–789CrossRef
12.
go back to reference Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller EA (2002) The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 24(6):521–529CrossRef Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller EA (2002) The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 24(6):521–529CrossRef
16.
go back to reference Navazesh M, Kumar SK (2008) University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl):35S–40SCrossRef Navazesh M, Kumar SK (2008) University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl):35S–40SCrossRef
18.
go back to reference Sreebny LM (2000) Saliva in health and disease: an appraisal and update. Int Dent J 50(3):140–161CrossRef Sreebny LM (2000) Saliva in health and disease: an appraisal and update. Int Dent J 50(3):140–161CrossRef
19.
go back to reference Reisine S, Morse DE, Psoter WJ, Eisenberg E, Cohen D, Cleveland D, Mohit-Tabatabai M (2005) Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia. J Oral Maxillofac Surg 63(4):513–520CrossRef Reisine S, Morse DE, Psoter WJ, Eisenberg E, Cohen D, Cleveland D, Mohit-Tabatabai M (2005) Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia. J Oral Maxillofac Surg 63(4):513–520CrossRef
23.
go back to reference Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS (2017) Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 6(12):2918–2931. https://doi.org/10.1002/cam4.1221 CrossRefPubMedPubMedCentral Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS (2017) Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 6(12):2918–2931. https://​doi.​org/​10.​1002/​cam4.​1221 CrossRefPubMedPubMedCentral
24.
go back to reference Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C (2018) Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg 16. https://doi.org/10.1111/idh.12363 CrossRef Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C (2018) Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg 16. https://​doi.​org/​10.​1111/​idh.​12363 CrossRef
28.
Metadata
Title
Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer
Authors
Laura Izabel Lampert Bonzanini
Eloisa Barbieri Soldera
Gabriela Barbieri Ortigara
Riéli Elis Schulz
Raquel Pippi Antoniazzi
Thiago Machado Ardenghi
Kívia Linhares Ferrazzo
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05008-4

Other articles of this Issue 4/2020

Supportive Care in Cancer 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine